-------
? s
il to indicate ceri
text of certificat
id-
eation as to information on this page
is on page one).
a
K
n
1
•rowing anlavl rapallents (1)
O
X
w
•0
00
1
n
00 00 00 00 09 09
i i i i ii
n
tout* oral toxicity-rat (1,36,37]
tcutaderawl (1,2,37)
toxic Ity-rabblt/rat
(cute inhalation toxicity-rat
>ria»ry eye irritation-rabbit (2)
>ria»ry denacl irritation (1,2)
>*rawl aanaitixatlon (4)
ficacv - Vertebrate Control taejita
noon on
BESS XX
M M M M MM
X X X X XX
XXX X XX
0 O O O O O
XXXX XX
n n n n n n
a a a a a a
o o o o o o
U 01 (0 (0 CO (A
1 1 1 1 1 1 1
H O * 09 «J 0\ Ul
&
FleaMbiltty . (11)
•xplodablllty (12)
ttoraga atabillty
Macoaity (13)
Macibitity (U)
:orroaion characteristics
Halactrlc braakdowt voltag* (IS)
nt* Toxic * Reoular Cheailcal
CD CD CD 00 CD CD CD
o n n n n n n
xac xxx x x
X XXX X XX
XX X X XXX
o o o oo o o
^axacxxxx
W W W M W PJ
tv4 iri frt tft *rt 5rt
a 9 a a a a a
o o o o o o o
in in to u co en w
II*
In
Wl
a
M
I
i"
r-cwno-oan
-
— w ^
~ 15
« zl
"0 Ok
ft
E;
5 f*
o
•n B
| 1,
1
jf
5
r
M 09 •
W *
CD B.
iaQ 01
G0 II
as ts
o
salts
. 53219-5
W
M 13 o
•MJ PIQ 0)
O «
U> G |
w H <
* W „
i -o s.
90 n a
o n S
1 M
NJ 1]
W M
w n
VO
II
jl
S n
rl
if
ts
• print in ink. Plaaae read carefully
wcataary.
%
"
1
ft
p*
1
«•*
!
|
i
tion requested
S
V
at
o
United States Enviroi
Wash ing t<
RBQUIREMEMTS STATUS J
z a 9
o • »
3
98 O ft
55 ' tt
M n
m wo
5 o rt
* O ft
W H-
O
§ 3
n <
f ^ I
1 * f
i ? i
? 2
NJ
S
T3
*Q
111
O
(V!
-------
!?i;*!-i*sfi i
y8i:s?ra|al; t
fff*
5 M.»!iig!
;;ii«
3 '
o — 1 — —
" * *
ft a <» — o
'*'
liliiili liljHKiJi
IStfsrl ? 1?
siimi fii
fMk
-------
I 5a««'
« * a D s
-i a ^ »» «i
vi n ^
-i n ia e a
. 3 ™ -n ~
S -•§ ? S
m
m
8
n I
if 3
[1 «
i S 3
2.? E'
~3 £
3 ~ C
si £
SI I
?J |
S §
I
y
G
H-
ft
(D
a
SM «*
I "
1h K S »
M * W
a 2 w
3 S 3" W
a 2 H-3
S 3 <
Z S «fi H-
ft S rt n
s s M
•• s - 3
S »
* M 03
o M • rr
« 3 a
w 2 O i-
Cft
S
•o
ft
n
c
M
93
5
13
w n
o o
*• ft
tTi (0
o o
ft
M-
o
3
(D
-------
•* 8
*
5 «** s
I lit I
it!??
i!
ft
W» w» W V V Wl V* V V w*
WWUWUUMION) l-»
I i I I I I I I I I
HHoJJfcWMWMH M
AN —-
I I
tO H
S 22
I -SUs
I ir,'!
«r o S •»
t
*
8
f!
.»•»
-:I
|j]i HP Q0 {0 pp jp|} Q3 no 00 03
oonnooooo n
XXXXXXXXX X
MMMHMHMHH H
Ql^tlQL^CHC^C^Ui L|
XXXXXXXXX X
ooooooooo o
09 C0
on
X X
H M
C-l C-l
XX
o o
XXXXXXX
XX
^3 T3
OQOQ030D00030DOOOO CD
983993999 9
OOOOOOOOO O
wwwwnwtnww n
03 09
!§
n w
• »
!f(
» 3
s
««
ft
S5
14
a w
n
5
99
tfl
9S
O
III
W
SO
I
•
w
M
i
n
Q)
ft
10
o » &
^fc O »
O g,
yisi
*o M ";
I "0 2,
50 H n
DO°
I M -
W 1]
Ck) HH
•^ n
fi
I!
I
|
I
•
I
&
i
|
I
n
(0
^*
Of
> 79
3 5^-
tn >o n
^ cTS
3 8
O -
3
O ft
n
w o
o ft
*" n
-------
? '
it to indicate cert
text of certifies!
ification as to information on this page
ion is on page one).
e
at
«
n
i
\O
I
«
•rowing «niMt repellents (1)
>
8
«
»
»0
03
a
o
tn
09 OD 0) 03 03 0} OvOv^O^O^O^O^
1 1 1 1 II 1 1 1 1 1 1 1
H O VD 0» -0 0» W
S e -o -o » »» 5 o n a < •> m *i
! !!{!! lill! 1
r » 3 3 £• • • li n •< IL •• a
[ S. m » t *• rf l_ p »• w .5 *
A »» s — • •» of e to *•• — •<
• — , — -i — t x Bf » -i —
r w •> a D — ij 5 • —
* * «. .*. 3 •*• n K & *> "
1 £">•»•• — » K ft ^
W w^ft)'*^ P* W fit
• gS^BS t P |l
1 ssff" 2 b ;s
1 8 i^ 1 s 8
r Is El
> #* «• *^
5^^ *^ ««S ^"k #* *N ^»k ^^ *% ^
£.•*£; ."^ s *tw si
» N "£ VVWMW
%^ » e«
3ij
»» » >»»»
CD OP QQ C^ CD CD CD CD CD CD CD CD CD
oooo no o o o o o n o
a x x x xx xxxxxxx
X*X* X* XXXXXWX
acsEtcac ax aExxxxxa;
oooo oo ooooooo
PC ae ac at ae z K ac ae z at x at
w ra w ra nn nnnnnn
13 *0 **O "0 "0 T5 ''O *0 'O "0 TJ ^0
9939 99 9999959
oooo oo ooooooo
noitnn inn tnuintotAwu
IF
Hi
II
3i
m
•
«
V*
~«
»«
*
>~OOCI IU*M
-
"fi
« "g
5?
"c
Is
f-:
!?
•*> a
'f
* «
* .
5 <>
a IB
8 «
*•»
-1
r
W W 36 S
Js. uo •
pany nBMe and nodr
rCOGEN CORP(
LSI OBERLIN
kN DIEGO CA
ess.
DRATION
DR.
92121
fw
3 08
> S"
w •
99 •
A &
*0 W,
• OB
S 8
5 .•«
salts
i. 53219-6
M
H t3 o
O 33 »
»k O «
wli
W-. Li
N> HS"
I-* 8
* « *
i v a
JO W o
DOS
1 M
to T]
W M
A O
O
Is
si
£3
fi
• ••
if
• *
-3
* or print in Ink. Please read carefully
if nececMry.
1
•
**
*+
3
R
r*
I
i
I
•<
1
*t
%
"^
r*
&
S
*«
»
«i
o
United States Enviroi
Washingtc
REQUIREMENTS STATUS 1
Z 3§
O * »
3
n • o>
o »-•
H n
Tn • ^o
^3 ^
SB NO
5 o ft
Z * (D
^3 O» O
«• O ft
M H-
O
W >
5 vfi
•I §
(A O
W *<
f 1 s-
1 ?|
H. S 1
* S |
5' 2
1! o
•s
IV
W
•o
l\>
•0
oa
ii>
N)
O
H)
K *
-------
5? *.
•- I
s
ssl 4"" r
I
a n x m n
"'!'
— O 3 • •> —
< 5 8 ><••<
rv
I?
l'
— on.
^ «•« <^
v. ~ -a
111 ^
(v
s;
si
I
^T
II
*
I "
: I
H!* fill i ;
g»0 •• ° - „ IS 8
"«?«•" a-I "" £•
«* ^t
is;
iii* • Rs. 3' ff
ii!1!S;« I
I*
I
• • •
? ll j I !?J
4! *•» * K » 8»
g> 5" »" S f •* A
1 f| § - 3*3
A 1* s i si I"
""•• Sr» 2 »* o o
i " s a. s 8 -
3 » -i «» • * e — •
* Ml? ?ll
11 ; ; ill
f| •«!•**
* • d • — •-»
»» « B — o • —
ft i * f}i
H i I Jrf
I R = "" • * "*
56, *» ^^ 5. ** -t.
|S 3 £ SS^
!• i I il?
M! 5 ** O U* m n
••. «. • *• «.
rt 3 a • — O
"a I * 8^1
!S " * ?-.
&J g I 5.5^
5 3 | 2. S ? 3!
6. S S. • S " w<
« 9 •» a a
&? ; a I ?
s « ft a ••
HI
t
j
!:
a a -
" " E
I II?
a IIS
O 9 •*
s
s
:i
!l»
A
"""
Bcss
\\'~'.
i
• i rit
5J •• 2.
ill *
If I
II
in — 5 n — — i
O «- m
j. 3 - .
5- 5 S' A
s si
5S.S
«if
n S
I
T a.
II*
f -«
K &
!k A
S tt
a, o en
01 « ^
ftrt ^^
% •* S (D
D, S S"
g, 1 2^
3 3 <
x e to H-
rt i
- 8
ro
O3
• ft
0>
O M
A.
©
H
1
H
O 0
*. rt
o\ n
o n
rt
H-
o
(D
W
CD
vQ
(5
O
rtv
-------
\ i
* s
S.&IS5 f
|i|»i !
HI ill
2. 2 5 1 a. » •
o 3 •._r„
o o • "* •»
il*:;"
5 "*c o •> o
* ,a 11
I 8 I 13
51 «5 *"*
«S* £5
»:H!
,
X <• -• o_ x >»
O 2. -* -D S 2.
! J?»H
T B -1 ~ 111
< m n T
I ij**-
| 5=-s||
i rfgi:
B SS
ftf S
— i •»
r-' I
K *» M
«z &
z" g
ly I
5 •» •
si i'
Xn ?
r 5- S-
* s
0 S
S o
EY
CO
rt
D>
._ *%
o o g«
s I s?
- s 3*
S r*"*t
H §i
g *3i
* « 03
O «. • ft
« 2 »
w 2 o»-
o 55. o o
T3 2 ffi ffl
O
w
S
s
n
-------
%
f UNITED STATES ENVIRONMENTAL PROTECTION AGENCY
MA4HINGTON. O.C. 204tO
XL 2 9 06
PF NOTICE 86-5
NOTICE TO PRODUCERS, FORMULATORS, OISTRI1UTORS
AND REGISTRANTS
Attention! Person* responsible for Federal registration of
pesticides.
Subjects Standard format for data subaitted under the Federal
Insecticide, Fungicide, snd Rodenticide Act (PXFXA)
and certain provisions of the Federal Food, Drug,
and Cosmetic Act (FFDCA).
I.
To require data to be submitted to the Environsiental
Protection Agency (EPA) in a standard format* This Notice also
provides additional guidance about, and illustrations of, the
required formats.
XZ. Applicability
This PR Notice applies to all data that are submitted to EPA
to satisfy data requirements for granting or maintaining pesticide
registrations, experimental use permits, toleraneee, and related
approvals under certain provision* of F1FRA and FFDCA. These
data are defined in FIPRA SlO(dHl). This Notice does not apply
to commercial, financial, or production information, which are*
and must continue to be, submitted differently under separate
cover.
III. Effective Date
This notice is effective on November 1, 1916. Data formatted
according to this notice may be submitted prior to the effective
date. As of the effective date, submitted data packages that do
not conform to these requirements may be returned to the submitter
for necessary revision.
XV. Background
On September 2«, 1»M, EPA published proposed regulations
in the federal Register (49 Pit 37956) which include Requirements
for Data Submission (40 CPU 1159.32), and Procedures for Claim*
of Confidentiality of Data (40 CFR S1S8.33). These regulation*
-------
specify the format for data submitted to EPA under Section 3 of
FIFRA and sections 408 and 409 of FFDCA, and procedures which
must be followed to make and substantiate claims of confiden-
- ality. N" *ncitl .its i l.i'.a * -fide.." \al it/ are c;ufuz2,
either by the proposed regulation or by this notice.
OPP is making these requirements mandatory through this
Notice to gain resource*saving benefits from their use before the
entire proposed regulation becomes final. Adequate Iea4 time is
being provided for submitters to comply with the new requirements.
v« Relationship of this Notice to Other OPP Policy and Guidance
While this Notice contains requirements for organising and
'formatting submittals of supporting data, it does not address
the substance of test reports themselves. 'Data reporting'
guidance is now under development in OPP, and will specify how .
the study objectives, protocol, observations, findings, and
conclusions are organised and presented within the study Deport.
The data reporting guidance will be compatible with submittal
format requirements described in this Notice.
OPP has also promulgated a policy (PR Notice 36-4 dated
April 15, 1986) that provides for early screening of certain
applications for registration under PZKRA S3. The objective of
the screen is to avoid the additional costs and prolonged delays
associated with handling significantly incomplete application
packages. As of the effective date of this Notice, the tcreen
will include in its criteria for acceptance of application
packages the data formatting requirements described herein.
OPP has als6 established • public docket which imposes dead-
line.* for inserting into the docket documents submitted in con-
nection with Special Reviews and Registration Standards (see
40 CFR $154.15 and $155.32). To meet these deadlines, OPP is
requiring an additional copy of any data submitted to the docket.
Please refer to Page 10 for aore information about this requirement,
For several years, OPP has required that each application for
registration or ether action include a list of all applicable
data requirements and an indication of how each is satisfied—the
statement of the method of support for the application. Typically,
many requirements are satisfied by reference to data previously
submitted—either by the applicant or by another party. That re-
quirement it not altered by this notice* which applies only to
data submitted with en application.
vz. Format Requirements
A more detailed discussion of these format requirements
follows the index en the next page, and samples of some ef the
requirement* ere attached. Except for the language of the two
alternative forma ef the Statement ef Data Confidentiality Claims
(shown in Attachment 3) which cannot be altered, theae samples
are illustrative. Aa long at the required information io included
and clearly identifiable, the form of the samples may be altered
to reflect the submitter's preference.
-------
- INDEX -
A,
B,
r.
D.
f ,
F.
G.
*
I
Organization of the Submittal Package ........
C.I Special Considerations for Identifying Studies. .
D. 2 Statement of Data Confidentiality Claims
(based on FIFRA S10(d)(D)
D. 4 Supplemental Statement of Data Confidentiality
Claims (other than those based on FIFRA flO(d)U))
0.5 Good Laboratory Practice Compliance Statement . .
Physical Format Requirements ft Number of Copies . . .
Special Requirements for Submitting Data to the Docket
r*
-------
B. Transffittal Document
The first ittm in tach submittal package must 0* a trans*
.?:f:-l '*?-•«.-. *'-i - •* "•• •-. ii-M-,'-. i; ies the s.rir..;*. .-r ir a*. I
joint submitters; the regulatory action in support of which the
package is being submitted—i.e., a registration application,
petition, experimental use permit (EUP), §3(c)(2HB) data call-in,
56(a) (2) submittal, or a special review; the transmittal date;
and a list of all individual studies included in the package in
the order of their appearance, showing (usually by Guideline
reference number) the data requirement(s) addressed by each one.
The EPA-assigned number for the regulatory action (e.g. the
registration, EUP, or tolerance petition number) should be
included in the transmittal document as-well, if it is known to
the submitter. See Attachment 1 for a.n example of an acceptable
transmi.teal document.
The list of included studies in the transmittal of a data
submittal package supporting a registration application should
be subdivided by discipline, reflecting the order in which data
requirements appear in 40 CFR 158.
The list of included studies in the transmittal of a data
submittal package supporting a petition for tolerance or an
application for an EUP should be subdivided into sections A, B,
C,..., of the petition or application, as defined in 40"CFR
180.7 and 158*125, (petitions) or Pesticide Assessment Guidelines,
Subdivision I (EUPS) as appropriate.
When a submittal package supports a tolerance petition and
an application for a registration or an CUP, list the petition
studies first, then the balance of the studies. Within these
two groups of studies follow the instructions above.
C. Individual Studies
A study is the report of a single scientific investigation,
including all supporting analyses required for logical complete-
ness. A study should be identifiable and distinguishable by a
conventional bibliographic citation including author, date, and
title. Studies generally correspond in scope to a single Guide-
line requirement for supporting data, with some exceptions dis-
cussed in section C.I. Each study included in • submittal package
must be bound as a separate entity. (See comments on binding
studies on page 9.)
Each study aust be consecutively paginated, beginning from
the title page as page 1. The total number of pages in the com-
plete study must be shown on the study title page. In addition
(to ensure that inadvertently separated pages can be reassociated
with the proper study during handling or review) use either of
the following!
• Include the total number of pages in the complete study
on each page (ie,, 1 of 250, 2 of 250, ...250 of 250).
- Include a company nan* or mark and study number on each
page of the study, e.g., Company Name-1986-23. Never reuse
a study number for marking the pages of subsequent studies.
-------
When a single study is extremely long, binding it in
volumes is permissible so long as th* e«t«re *tj-1y i* ja-it*:-!*
.:. ^ *;r.»i«; »*.i*<» *r,c «a>.n , and if so must be handled
ss described in section 0.3* of this notics.
-------
c. Residue Chemistry studies. Guidelines 171-4, 153-3,
^1-4 AT* *xr.r«"el" uread ir. «row *tj-iies nd-lressinc,
aje en em 1$ try requirement* /tusc t«i»a o« uwtiOeO §c d
lev*! below that of the Guideline code. The general principle,
however, of limiting a study to the report of a single inves-
tigation still applies fully. Data should be treated as a
single study and bound separately for each analytical method,
each report of the nature of the residue in a single crop or
animal species, and for each report of the magnitude of resi-
dues resulting from treatment of a tinglt crop or from proces*
sing a single crop. When more than one commodity it derived
from a single crop (such as beet tops and beet roots) residue
data on all such commodities should be reported as • single
study, when multiple field trials are-associated -»ith •
single crop, all such trials should be reported as « single
study.
D. Organization of Each Study Volume
Fach complete study must include all applicable elements in
the list below, in the order indicated. (Also see Page 17.)
Several of these elements are further explained in the following
paragraphs. Entries in the column headed 'example' cite the
page number of this notice where the element is illustrated.
Element
Study Title Page
Statement of Data
Confidentiality
Clauns
Certification of Good
Laboratory Practice
•
Flagging statements
Body of Study
Study Appendices
Cover Sheet to CenfI*
dential Attachment
CBI Attachment
Supplemental Statement
of Data Confidentiality
Claims
When Require.' Example
Always page 12
One of the two alternative Page 13
forms of this statement
is always required. '
If study reports laboratory Page 16
work subject to CLP require-
ments
For certain toxicology studies. (When
flagging requirement* are finalised.)
Always - with an English language
translation if required.
At submitter's option
If CBI is claimed under FIFRA
flOfdHlUA), (B>, or (C)
If CBI is claimed under FIFRA
, «20(d)fl)(A>,
-------
D.I Titl* Pag*
A title page U Always required for each submitted study,
published or unpublished. The title page must always be £r*«ly
releasable to requestors; DO NOT INCLUDE CBI ON THE TITL* PACE.
An example of an acceptable tir.le page is on page 12 of this
notice. The following information must Appear on the title
page:
a. Study title. The study title should be as descriptive as
possible. It must clearly identify the substance(s) tested and
correspond to the name of the data requirement as it appears
in the Guidelines.
b. Oata requirement addressee. Include on the title page the
Guideline numberls) of the specific requirement!s) addressed by
the study.
c. Author(s). Cite only individuals with primary intellectual •
responsibility for the content of the study. Identify them
plainly as authors( to distinguish them from the performing
laboratory, study sponsor, or other names that may also appear on
the title page.
d* Study Date. The title page must include a single date for
the study. If parts of the study were performed at different
times, use only the date of the latest element in the study.
e. Performing Laboratory Identification. *lf the study reports
work done by one or more laboratories, include on the title page
the name and address of the performing laboratory or laboratories,
and the laboratory's internal project number(s) for the work.
Clearly distinguish the laboratory's project identifier from any
other reference numbers provided by the study sponsor or submitter.
f« Supplemental Submissions. If the study is a commentary on
or supplement to another previously submitted study, or if it
responds to CPA questions raised with respect to an earlier study,
include on the title page elements a. through d. for the previously
submitted study, along with the EPA Master Record Identifier (MRID)
or Accession number of the earlier study if you know these numbers.
(Supplements* submitted in the same submittal package as the primary
study should be appended to and bound with the primary study. Do
not include supplements to more than one study under a single
title page).
. • ,
g. factsof Publication. Xf the study is a reprint of a pub-
iished document, identify on the title page all relevant facts
of publication, such as the journal title* volume, issue* inclusive
page numbers, and publication date.
-------
D.2. Statements of Data Confidentiality Claims under FIFRA §10(c!
-------
This statement is required if the study contains laboratory
work subject to CLP requirements specified in 40 CFR 160. sam-
ples of these statements are shown in Attachment 6.
E, Reference to PreviouslySubmitted Data
DO NOT RESUMIT A STUDY THAT HAS PREVIOUSLY BEEN SUBMITTED
FOR ANOTHER PURPOSE unless EPA specifically requests it. A copy
of the title page plus the MRID number (if known) is sufficient
to allow us to retrieve the study immediately for review. This
prevents duplicate entries in the Agency files* and saves you
the cost of sending more copies of the study. References to pre-
viously submitted studies should not be included in the transmit-
tal document, but should be incorporated into the statement of
the method of support for the application.
r.. Physical Format Requirements
All elements In the data submittal package must -be on uniform
S 1/2 by 11 inch white paper, printed on one side only in black
ink, with high contrast and good resolution. Bindings for indi-
vidual studies must be secure, but easily removable to permit
disassembly for microfilming. Check with EPA for special
instructions before submitting data in any medium other than
paper, such as film or magnetic media.
Please be particularly attentive to the following pointsi
o Do not include frayed or torn pages.
o Do not include carbon copies, or copies in other than
black ink.
o Make sure that photocopies are clear, complete, and fully
readable.
o Do not include overtise computer printouts or fold-out pages.
e Do not bind any documents with glue or binding tapes.
o Make sure that all pages of each study, including any attach-
ments or appendices, are present and in correct sequence.
Number of Copies Required - All submittal*packages except
those associated with a Registration Standard or Special Review
(see Part 6 below) must be provided in three complete, identical
eopiea. (The proposed regulations specified two copies* three
are now being required 'to expedite and reduce the coat of proces-
sing data into the OFF Pesticide Document Management System and
getting it into review.)
-------
G. Special Requirements for Submitting Data to the Docket
Data suomittal packages associated witn a registration Scan*
dard or special Review must be providtd in four copies, from on*
of which all mattrial claimed as CBI has bwtn excised. This
fourth copy will become part of the public docket for the RS or
SR c«se. 1C no claims of confidentiality are made for the study,
trie fourth copy should be identical to the other three. Whan
portions of a study submitted in support of an RS or SR are
claimed as CBI, the first three copies will include the CBI
material as provided in section 0 of this notice. The following
special preparation is required for the fourth copy.
o Remove the 'Supplemental Statement- of Data Confidentiality
Claims'.
o Remove the 'Confidential Attachment*.
o Excite from the body of the study any information you claim
as confidential, even if it does not fall within the scope
of FIFRA llO(d)UHA),
-------
ATTACHMENT 1.
CLEMENTS TO BE INCLUDED IN THE TRANSMITTAL DOCUMENT*
1. Name and address of submitter (or all joint submitters**)
TSmith Chemical Corporation Jon«s Chemical Company
1214 west Smith Street -and-' 5678 Wilson Blvd
Cincinnati, OH 98765 • Covlngton, KY 56789
fSAith Chemical Corp. will act as sole agent for all submitters.
2. Regulatory action in support ct which this package is submitted
Use the EPA identification number (e.g. 359-EUP-67) if you
know it Otherwise describe the type of request (e.g. experi-
mental use permit, data call-in - of xx-xx-xx date).
3. Transmittal date
4. List of submitted studies
vol 1. Administrative materials - forms* previous corres-
pondence with project Managers, and so forth.
Vol 2. Title of first study in the submittal (Guideline No.)
•
* *
•
vol n. Title of nth study in the submittal (Guideline No.)
* Applicants commonly provide this information in a trans-
mittal letter. This remains an acceptable practice so
long as all four elements are included.
** Indicate which of the joint submitters is empowered to
act on behalf of all joint submitters in any matter con-
cerning data compensation or subsequent use or release
of tht data.
Company OffleiAlt
Name Signature
Company Namei '
Company Contacts _^_^^^^__^^^_^^^__ _,,
Nam* Phone
-------
ATTACHMFNT 2.
SAMPLE STUDY TITLE PACE FOR A NEWLY SUBMITTED STUDY
Study TitU
(Chemical namt) - Magnitudw of Rtsidu* on Corn
Data tHquir«»ant
Guidallna 171-4
Author
John C. Davia
Study Complatad On
January 5, 1979
Ptrtorroing Laboratory
ABC Agricultural Laboratori«a
940 H«»t Bay Orlva
Wilmington, CA 39897
Laboratory Project ID
ABC 47-79
Pag* 1 of X
(X ia th« total numbtr of pagaa tn tha studyI
-------
JCTAWEJ.T 3.
STArmofis or DATA ooNnDevn«.m CLAIMS
1. NO claim of confidantiality jndar FIFRA $10(d)(l)(A),(B), or (C)
stnworr or NO DMA ODNFinxriALmr CLAIW
No claim of cunCidontlality it mada for any information oantainad in this starty
on tha basis of its fining within tha seep* of FIPRA $10{d)(l)(A), (B), or (C).
TiU» Signature
2. Claim of eonfirttntialtty undtr FIFWk flO(d)(l)(A), (B), or (C).
Or OAXA OCNTICEWriALmf CIAZMS
Information clainvd confidantial on tha baais of its falling within tha scope
of FIFRA flO(d)(l)(A)» (B), or (C) htf ha«n ranovad to a oonfidantial appandix,
and is eitad by crosa-rtfsranca nmtoar in tha body of tha audy.
Oanpanyt
Ooapany Agentt TVpsd Vmm Bitai
Tttla Siqnaturs
NORt Applicants for pamanant or tan^orary tolaranca* should note that it
is OPP policy that no patraanant tolaranoa, tanporary tolaranoa, or raquast for
«n aasitfsnuy ajw^ption incorporating an analytical raathod, can ba approval
unlasa tha applicant waivM all elains of confidantiality for tha analytical
•attad. Ihsa* analytical •athoda ar» publishsd in tha FM Paaticioa Analyt-
ical Hftthodi Nanial, and tharafora cannot ba clainad as confidantial. OPP
jnylsajsnu this policy by raturning subnittad analytical nathods, for «tiich
which confidantialicy elaiM havs baan aaUt, to tha s^mittar, to obtain
tha coftfidantiality waivar bafora thsy can ba
13
-------
ATTACHMENT 4.
SUPPLEMENTAL STATEMENT OF DATA CONFIDENTIALITY CLAIMS
for any portion of • submitted study that is not described
by FIFRA SlOtdXIHA),
-------
EXAKPLES OP SEVERAL CONFIDENTIAL ATTACHMENTS
aBsle 1 (Confidential word or phrase that has been deleted fron the study)
I
CfOSS REFERENCE NUMBER 1 This crQM reference number is used in th* study !
in place of the following words or phrase at the I
indicated volume and page references.
OELETH) WORDS OR PHRASEi EthvUm Clvool-
fftt LINE REASON FOR THE DELETION FIFRA REFERENCE
6 14 Identity of Inert Ingr»di«nt flOfdHlHC)
28 25 ' .
100 19
It 2 (Confidential paragraph(sj^ that have bMn deleted from the study)
CROSS .1CFEREHCE NUMBER 5 This cross reference amber is used in the study
in place of the following paragraphs ) at the
indicated \clkiw and page references.
OELEflD'BIBM3APH(S> I
( )
< Reproduce the deleted paragraph; s) here )
( . )
.LIMBS REASON FOR TOE DELETION FTFRA REFERENCE I
. - (
20 «-T7 Description of the quality control process SlOtdHlHC)
IConf idential osoes that have been deleted from the study)
NUMBER 7 this crass reference number noted on a place-holder
page is used in place of the following whole pages
at the indicated volume and page references.
attached Immediately behind this page.
HCTT8) REASON FOR THE DELETION riFEA REFERENCE
39-41 Description of product manufacturing process |10
-------
ATTACH"™? *5.
SAMPLE GOOD LABORATORY PRACTICE STATEMENTS
Example 1.
This study meets th* requirements for 40 CFR Part 160
Submitter ^____________m________-______—.
Sponsor ...
.Study Director
Exampl* 2.
This study dots not meet th« rsquirwntnts of 4C CPR
Part 160, and differs in th« following wayst
1.
2.
3.
Submitter
Sponsor
Study Director
Example 3*
The submitter of this study was neither the sponsor of this
study nor conducted it, and does not know whether it has
been conducted in accordance with 40 CFR Part 160.
Submitter .
-------
ATTACHMENT 7.
FORMAT OP THE SUBWITTAL PACKAGE
LEGEND
Tranamittal OoeuiMnt.
Related Administrative Material*
(e.g.. Method of Support Statement, etc.)
I Other materials about the aubmittal
— — (e.g., summaries of group* of studies
to aid in their review).
Studies, submitted a* unique
phy*ieel entities, according
to the format below.
FORMAT OP SUBMITTED STUDIES
Study title page.
Statement of Confidentiality Claims.
GLP and flagging* statements - as appropriate.
Body of the study, with English
language translation if required.
Appendices to the study.
Title Page of the Confidential
Attachment.
Confidential Attachment.
-1 Supplemental Statement
, . * of Confidentiality Claims.
' When flagging requirement*
arc financed.
Documents.which must be submitted as
appropriate to meet established requirements.
•l
I Documents submitted at submitter's option,
-------
ATTACHMENT D
EPA GROUPING OF END-USE PRODUCTS FOR MEETING
DATA REQUIREMENTS FOR REREGISTRATION
-------
IPA'S BATCHING OF END-USE PRODUCTS CONTAINING SOAP SALTS AS TEE
ACTIVE INGREDIENT FOR MEETING ACUTE TOZICITY DATA REQUIREMENTS FOR
RBREGISTRATION
In an ««.jr.*~t to reduce the time, resources and number of
animals needed tx fulfill the acute toxicity data requirements for
reregistratiT z2 end-use products containing the active
ingredients so*2 salts, the Agency has batched products which can
be considered similar in terms of acute toxicity. Factors
considered in the sorting process include each product's active and
inert ingredients (identity, percent composition and biological
activity), type of formulation (e.g., emulsifiable concentrate,
aerosol, wettable powder, granular, etc.), and labeling (e.g.,
signal word, use classification, precautionary labeling, etc.).
Note that the Agency is not describing batched products as
"substantially similar" since some products within a batch may not
be considered chemically similar or have identical use patterns.
Batching has been accomplished using the readily available
information described above, and frequently acute toxicity data on
individual end-use products has been found to be incomplete.
Notwithstanding the batching process, the Agency reserves the right
to require, at any time, acute toxicity data for an individual end-
use product should the need arise.
Registrants of end-use products within a batch may choose to
cooperatively generate, submit or cite a single battery of six
acute toxicological studies to represent all the products within
that batch. It is the registrants' option to participate in the
process with all other registrants, only some of the other
registrants, or only their own products within a batch, or to
generate all the required acute toxicological studies for each of
their own products. If a registrant chooses to generate the data
for a batch, he/she must use one of the products within the batch
as the test material. If a registrant chooses to rely upon
previously submitted acute toxicity data, he/she may do so provided
that the data base is complete and valid by today's standards (see
acceptance criteria attached), the formulation tested is considered
by EPA to be similar for acute toxicity, and the formulation has
not been significantly altered since submission and acceptance of
the acute toxicity data. ' Regardless of whether new data is
generated or existing data is referenced, registrants must clearly
identify the test material by EPA Registration Number.
In deciding how to meet the product specific data
requirements, registrants must follow the directions given in the
Data Call-In Notice and its attachments appended to the RED. The
DCI Notice contains two response forms which are to be completed
and submitted to the Agency within 90 days of receipt. The first
form, "Data Call-In Response," asks whether the registrant will
meet the data requirements for each product. The second form,
"Requirements Status and Registrant's Response," lists the product
specific data required for each product, including the standard six
acute toxicity tests. A registrant who wishes to participate in a
-------
batch must decide whether he/she will provide the data or depend on
someone else to do so. If a registrant supplies the data to
support a batch of products, he/she must select one of the
following options: Developing Data (Option l), Submitting an
Existing Study (Option 4), Upgrading an Existing study (Option 5)
or Citing an Existing Study (Option 6). If a registrant depends on
another's data, he/she must choose among: Cost Sharing (Option 2),
Offers to Cost Share (Option 3) or Citing an Existing Study (Option
6). If a registrant does not want to participate in a batch, the
choices are Options 1, 4, 5 or 6. However, a registrant should
know that choosing not to participate in a batch does not preclude
other registrants in the batch from citing his/her studies and
offering to cost share (Option 3) those .studies.
Soap salts refer to the active ingredients potassium salts of
fatty acids and ammonium salts of fatty acids. Batches 1,2,3, and
4 (Table 1) consist of products that have potassium salts of fatty
acids as the active ingredient. Batch 5 (Table 2) consists of two
products that have ammonium salts of fatty acids as the active
ingredient.
Table 1
Batch
1
2
EPA Reg. No.
239-2564
36488-32
36488-33
36488-36
42697-02
42697-10
42697-11
42697-13
42697-16
42697-22
.•---y?«ll ifcb.^' •
36488-31
42697-06
42697-35
53219-05
% Potassium
Salts of Fatty
Acids
2.0%
2.0%
1.5%
2.0%
2.0%
2.0%
. 1.5%
2.0%
1.5%
3.0%
',*V .-•
25.0%
25.0%
18.0%
18.0%
Formulation Type
Ready-To-Use .Solution
Ready-To-Use Solution
Ready-To-Use Solution
Ready-To-Use Solution
Ready-To-Use Solution
Ready-To-Use Solution
Ready-To-Use Solution
Ready-To-Use Solution
Ready-To-Use Solution
Ready-To-Use Solution
Emulsifiable Cone.
Ready-To-Use Solution
Emulsifiable Cone.
Emulsifiable Cone.
-------
3
4
42697-01
42697-15
53219-06
42697-07
53219-04
49.0%
50.5%
49.0%
40.0%
40.0%
Soluble Cone.
Soluble Cone.
Soluble Cone.
Soluble Cone.
Soluble Cone.
Table 2
Batch
5
EPA Reg. No.
400-383
400-429
% Ammonium
Salts of
Fatty Acids
15.0%
15.0%
Formulation
Type
Flowable cone.
Soluble Cone.
Table 3 lists those products the Agency was unable to batch.
These products were either considered not to be similar to other
products for purposes of acute toxicity or the Agency lacked
sufficient information for decision making.
Table 3
UNBATCHED PRODUCTS
EPA Reg. No.
42697-33
42697-34
CONTAINING SOAP SALTS AS THE ACTIVE
% Active Ingredients
0.07%
2.05%
1.40%
41.00%
- pyrethrum extract
- potassium salts of
fatty acids
- purified pyrethrum
extract
- potassium salts of
fatty acids
Formulation Type
Soluble Cone.
Soluble Cone.
-------
o o o o o
™* ^ 09 O M
•O •»< 0» O -O
> o o c n
n r™ ^ -• m
z » » » 2
8 ? £ 0 aj
3 -• — J »
522-5
-H r* r* > ^
3 n r* r»
1131
al
r» •«
3* > SO
o o m
55 |
If |
O
85 *
-m -H V*
»O 30
-* 3
"5 !
1 s
" 1
M
UJ....JJJ
Ul -* •— O
-**•**• J x
a m m 3 z
•• o o o ^
SI- r- !3
* * rn
m
VI M I/I CB »
^ »^ ^^ nt ••
2 2 S 5 1
8333
S Z IE
n ffk
33
Sg g § S
SssSS
n
o
z
o
o
TJ
0)
3
Z
Bl
3
n>
>
a
a
*~
ft
0
0)
z
(D
,,
a
a
n
n
n
n
0
rt
se>
Cfl
ft
D>
ft
O
5?
•a
»
s
^
fit
s,
01
3
" 3
3 <
*^ ^*
ft >1
O O
?1
A
O 3
• ft
01
a H-
•
^3
M I-J
0 0
* ft
01 (0
o o
rt
H*
"
0
3
>
(D
O
TJ
0»
(6
O
H>
-------
ATTACHMENT F
LIST OF ALL REGISTRANTS SENT THIS DATA CALL-IN NOTICE
-------
ATTACHMENT G
COST SHARE AND DATA COMPENSATION FORMS
-------
P/EPA
United States Environmental Protection Ageney
Washington, DC 20460
OU8 No. 207(M)1Q«
CERTIFICATION WITH RESPECT TO
DATA COMPENSATION REQUIREMENTS
form Approved
Approval Expire* 13-31.92
Public reporting burden for this collection of information Is estimated to average 15 minutes per response, including
time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and
completing and reviewing the collection of information. Send comments regarding the burden estimate or any other
aspect of this collection of information. Including suggestions for reducing this burden, to Chief, Information Policy
Branch, PM-223. U.S. Environmental Protection Agency, 401 M. St., S.W., Washington, DC 20460; and to the Office
of Management and Budget, Paperwork Reduction Project (2070-0106), Washington, DC 20503.
Please fill in blanks below.
Company HUM
CftoatMl NMM
Company Number
EPA CftemlMl Number
(Certify that
1 . For each study cited In support of rereglstratton under the Federal Insecticide, Fungicide and Rodenticide Act
(FIFRA) that is an exclusive use study, I am the original data submitter, or I have obtained the written permission of
the original data submitter to cfte that study.
2. That for each study died in support of reregistratton under RFRA that is NOT an exclusive use study, I am the
original data submitter, or f have obtained the written permission of the original data submitter, or t have notified in
writing the company(1es) that submitted data t have cited and have offered to: (a) Pay compensation for those data
in accordance with section 3(c)(1)(D) and 3(c){2)(D) of FIFHA; and (b) Commence negotiation to determine which
data are subject to the compensation requirement of FIFRA and the amount of compensation due, H any. The
companies I have notified art: (check one)
[] AB companies on the data submitters' Bst for he active ingredient Osted on this form (Cite-All
Method or Cite-All option under the Selective Method). (Also sign the General Offer to Pay
betow.)
sheets, or indicated on the attached •Requirements Status and Registrants' Response Form,*
3. That I riav* previously complied wftn section 3(C)(1XD) of FIFHA tor the studJts I have cfled In support of
reregistratton under FIFRA.
•IfMtiir*
Oil*
HUM sod Till* (HMM Typo or PttoQ
GENERAL OFFER TO PAY: I hereby offer and agree to pay compensation to other persons, win regard to the
reregfrtratton of my products, to th extent required by FIFRA section 3
-------
P/EPA
United States Environmental Protection Agency
Washington, DC 20460
CERTIFICATION OF OFFER TO COST
SHARE IN THE DEVELOPMENT OF DATA
Farm Approved
OMB No. 2070-0106
Approvil Explf»i 12-31.92
Public reporting burden for this collection of information is estimated to average 15 minutes per response, including
time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and
completing and reviewing the collection of information. Send comments regarding the burden estimate or any other
aspect of this collection of information, including suggestions for reducing this burden, to Chief, information Policy
Branch, PM-223, U.S. Environmental Protection Agency. 401 M St.. S.W., Washington, DC 20460; and to the Office
of Management and Budget, Paperwork Reduction Project (2070-0106), Washington. DC 20503.
Please fill in blanks below.
Company Nam*
Chemical Nun*
Company Number
EPA Chemical Number
i Certify that:
My company is willing to develop and submit tha data required by EPA under the authority of the Federal
insecticide. Fungicide and Rodenttode Act (FIFRA), if necessary. However, my company would prefer to
enter into an agreement with one or more registrants to develop jointly or share in the cost of developing
data.
My firm has offered in writing to enter into such an agreement. That offer was irrevocable and included an
offer to be bound by arbitration decision under section 3(c)(2)(B)(iii) of FIFRA if final agreement on all
terms could not be reached otherwise. This offer was made to the following firm(s) on the following
date(s):
of n*»(a)
Paw of Offer
leertymttlamdUyauthorbedtorepresaftlrieconvaty have made on
trasfonn art alattactvmts thereto ai* true, aeoirM^ t acknowledge that any knowingly false or
misleading statement may be purtsnaole by fine or imprisonment or bom urder applicable law.
Stouter* of CaBMftr** Autfwrfutf
Oat*
NMM and Tin* (Ploaa* Tyt* «r Mnf)
f»A fttm Sf704a
-------
-------